Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore

* Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 for eligible patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for autologous stem cell transplant and have received at lea...

2026-08-31 09:00 2724

Data4Life and Monash Health Announce Strategic Collaboration to Advance Clinical Research

Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving patient outcomes. - Picture is available at AP

2026-08-31 07:00 1857

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management

- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada. - Global Phase III clinical program to investigate efficacy and safety of three maintenance doses (20 mg, 40 mg, and 60 mg) over 72...

2026-08-30 18:15 3605

Tycoon Group Sustains Profitability: 2026 Interim Results Net Profit Surges 183% Year-on-Year

Business Demonstrates Strong Resilience, Profitability Continues to Materialise Results Highlights * Tycoon Group sustained its turnaround success from the previous year, recording a net profit of approximately HK$6.3 million during the Period (1H2025: net loss of approximately HK$7.7 millio...

2026-08-29 11:20 7996

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces

ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year ea...

2026-08-29 10:08 8688

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced the ...

2026-08-28 19:30 3494

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform

* Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming further clinical development and global commercialization * DUPAC, one of the DualityBio's four proprietary ADC technology platforms, comprises...

2026-08-28 12:20 2670

Singclean 2nd Leaders Summit Charts New Course in Global Aesthetics

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Hosted within the IMCAS China Conference venue at W Shanghai - The Bund, Singclean 2nd International Medical Aesthetic Leaders Summit themed "Global Vision, Embark on a New Chapter" came to a successful conclusion. 2026 IMCAS China Singclean Highlight Vid...

2026-08-28 11:00 2934

NECA Expands Telehealth Care with New Counselling and Dietitian Support

NeuroEndocrine Cancer Australia strengthens free specialist support for patients, carers, and families affected by neuroendocrine cancer. SYDNEY, Aug. 28, 2026 /PRNewswire/ -- NeuroEndocrine Cancer Australia (NECA) has expanded its national telehealth service to include dedicated counselling and...

2026-08-28 07:00 2630

NECA Expands Telehealth Care with New Counselling and Dietitian Support

Kazia Therapeutics Limited Announces Proposed Public Offering

2026-08-28 05:14 4067

Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer

Durable Complete Metabolic Response Ongoing Since November 2025 All Evaluable Patients Demonstrated Reductions in Metastasis-Associated CTC Clusters and Terminally Exhausted T cells, With Median Reductions of 83% and 51% Respectively No Treatment-Related Serious Adverse Events Observed SYDNEY, ...

2026-08-28 04:01 4506

Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care

MELBOURNE, Australia, Aug. 28, 2026 /PRNewswire/ -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and researchers, reducing the wait for genomic test results that can infor...

2026-08-28 04:00 5215

Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care

ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS

Now spanning ZEISS Retina and Cataract Workflows, the EVA NEXUS™ ophthalmic surgical system from ZEISS comes in a cataract-only configuration, bringing a tailored approach to different surgical needs. JENA, Germany, Aug. 27, 2026 /PRNewswire/ -- | Carl Zeiss Meditec AG

2026-08-27 21:03 2102

ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS

Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion

Highlights: * Total revenue reached RMB86.96 billion, and profit attributable to owners of the parent reached RMB1.72 billion, representing a year-on-year increase of 160.3%; * Operational quality of core industries steadily improved, with industrial operation profit reaching RMB3.69 billion...

2026-08-27 19:27 4272

AsiaPay Partners with Generika Drugstore to Launch a Convenient and Secure Digital Payment Solution, Enhancing Customer Payment Experience in The Philippines

MANILA, Philippines, Aug. 27, 2026 /PRNewswire/ -- AsiaPay, a leading digital payment service provider and technology company in Asia, has partnered with Generika Drugstore, the country's premier generic pharma retail chain and part of AC Health, the healthcare arm of the Ayala Group, to signific...

2026-08-27 17:31 3623

Sunway Medical Centre Penang Receives Dual Honours at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition for Healthcare Excellence and Brand Leadership

SINGAPORE, Aug. 27, 2026 /PRNewswire/ -- Sunway Medical Centre Penang (SMCP) has been honoured with the Corporate Excellence and Inspirational Brand awards at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition by Enterprise Asia, recognising its strong growth trajectory as a leading ...

2026-08-27 16:27 4437

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

HONG KONG, Aug. 27, 2026 /PRNewswire/ -- As a premier global landmark in biotech, BIOHK2026 convenes international biotech hubs, cross-disciplinary industry forums, and high-impact networking events to accelerate cross-border partnerships in Hong Kong.

2026-08-27 12:06 3857

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

Exascend Deploys Advanced Medical-Grade Storage Solutions to Power Next-Generation Healthcare Systems

TAIPEI, Aug. 27, 2026 /PRNewswire/ -- Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation medical systems. The enterprise-grade solution deliver...

2026-08-27 11:00 2808

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

BUENOS AIRES, Argentina, Aug. 27, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company's biologic...

2026-08-27 05:00 2900

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology

New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic cancer, glioblastoma, and other lethal malignancies NEW YORK, Aug. 26, 2026 /PRNewswire/...

2026-08-26 20:38 2971

1 ... 12 13 141516 17 18 ... 380